1
Exposure to HAART was not associated with receipt of lipid lowering therapy.
2
We investigated factors associated with receipt of chemotherapy in a diverse population-based sample.
3
No serious adverse events were associated with receipt of immunisation.
4
Logistic regression models were used to explore factors associated with receipt of laboratory tests.
5
We identified the frequency of PLND in low-risk patients and identified factors associated with receipt of PLND.
6
We used multivariate logistic regression methods to determine factors associated with receipt of different asthma self-management tools controlling for demographic factors.
7
Conclusion: In this population-based sample, disease characteristics were strongly associated with receipt of chemotherapy, indicating that clinical benefit guides most treatment decisions.
8
Gender, academic status at enrollment, ethnicity, tuition sponsorship, and earning an advanced degree were not associated with receipt of NIH grant funding.
9
We calculated cancer-directed treatment use rates, then used logistic regression to identify patient and health system factors that were associated with receipt of treatment.
10
Patient characteristics and clinical factors associated with receipt of palliative RT and RT intensity (total dose and number of treatments) were evaluated with multivariable regression.